ArticleCureus2025

Tumor Lysis Syndrome Triggered by Acalabrutinib in Chronic Lymphocytic Leukemia (CLL): Diagnostic and Therapeutic Implications.

Monsif Fadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.